Drugs and dollars News & Observer Duke University Health System charged $32,370 for rituximab, which treats lymphoma and leukemia. Duke settled for $19,420. Medicare would have allowed $6,420. Duke received $10,670 for a dose of Neulasta, which fights infections for those undergoing ... |
